Characteristics | Univariate | Multivariate | ||
HR (95% CI) | P value | HR (95% CI) | P value | |
Diameter of tumor (cm) | ||||
≤2 | ||||
>2 to ≤4 | 3.02 (0.92 to 9.91) | 0.069 | 2.83 (0.81 to 9.88) | 0.102 |
>4 | 2.61 (0.75 to 9.01) | 0.130 | 2.46 (0.66 to 9.22) | 0.179 |
Tumor grade | ||||
Grade 1~2 | ||||
Grade 3 | 1.01 (0.54 to 1.88) | 0.987 | 0.89 (0.46 to 1.74) | 0.742 |
Depth of stromal invasion | ||||
<1/2 | ||||
≥1/2 | 2.22 (0.94 to 5.22) | 0.069 | 1.51 (0.59 to 3.88) | 0.392 |
LVSI | ||||
No | ||||
Yes | 1.16 (0.65 to 2.06) | 0.625 | 1.07 (0.59 to 1.96) | 0.815 |
Parametrial involvement | ||||
No | ||||
Yes | 2.93 (1.24 to 6.90) | 0.014 | 1.28 (0.35 to 4.59) | 0.709 |
Surgical margins | ||||
Negative | ||||
Positive | 2.56 (1.23 to 5.29) | 0.011 | 1.37 (0.44 to 4.27) | 0.589 |
Vaginal involvement | ||||
No | ||||
Yes | 2.94 (1.46 to 5.91) | 0.003 | 3.13 (1.29 to 7.58) | 0.011 |
Number of positive LN | ||||
1 | ||||
≥2 | 1.68 (0.92 to 3.08) | 0.090 | 1.29 (0.65 to 2.53) | 0.465 |
Common iliac LN | ||||
Negative | ||||
Positive | 2.02 (1.03 to 3.96) | 0.042 | 1.49 (0.65 to 3.41) | 0.349 |
Adjuvant treatment | ||||
RT | ||||
CCRT | 0.64 (0.27 to 1.50) | 0.303 | 0.48 (0.20 to 1.17) | 0.107 |
SCRT | 0.45 (0.22 to 0.94) | 0.034 | 0.26 (0.11 to 0.57) | <0.001 |
CCRT, concurrent chemoradiation; LN, lymph node; LVSI, lymphovascular space invasion; RT, radiotherapy; SCRT, sequential chemoradiation.